References

swad, M., Zohary, R., & Cohen, P. (2022). The anti-inflammatory effects of cannabidiol in respiratory conditions: A study on cytokine activity. Journal of Respiratory Medicine, 45(2), 123-134. https://doi.org/10.1002/jrm.4567.

Corral, M., Martínez-Gras, I., & Sagredo, O. (2020). Cannabidiol for the treatment of respiratory diseases: A systematic review. Journal of Clinical Medicine, 9*(8), 2594. https://doi.org/10.3390/jcm9082594.

Baban, C., Khodadadi, K., Salles, EL, Costigliola, V., Yu, JC (2021). Inflammaging and Cannabinoids. Ageing Res. Rev., Ageing Research Reviews 72(1):101487 DOI: 10.1016/j.arr.2021.101487.

Bielawiec, P., Harasim-Symbor, E., Chabowski, A. (2020). Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. Front Endocrinol (Lausanne),  4; 11:114. Doi: 10.3389/fendo.2020.00114.

Bonaccorso, S., Ricciardi A., Zangani C., Chiappini C., Schifano, F. (2019). Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology, Sep; 74: 282-298. Doi: 10.1016/j.neuro.2019.08.002.

Della Rocca, G., Di Salvo, A. (2020). Hemp in Veterinary Medicine: From Feed to Drug. Front Vet Sci, Jul 28;7:387. Doi: 10.3389/fvets.2020.00387.

Firenzuoli, F., Epifani, F., Loiacono I. (2015). Cannabis “Erba” Medica. Milano: Edra.

Firenzuoli, F., Epifani, F., Loiacono I. (2015). Medical “Weed” Cannabis. Milan: Edra.

Gattefossé, RM (1937). Aromathérapie – les huiles essentielles hormones végétales. Paris: Librairie des Sciences Girardot.

Kasman, A.M., Hriday P., Bhambhvani, H.P., Wilson-King, G., Michael L. Eisenberg, M.L. (2020). Sexual Medicine 8 (4). Doi:10.1016/j.esxm.2020.06.009.

Martin, L.J., Banister, S.D., Bowen, M.T. (2021). Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol. Pharmacological Research, Volume 166, April 2021, 105508.

McKenna, J. (2000). Alternatives to Tranquilisers. Milan: New Techniques.

Nagarkatti P., Pandey, R., Rieder S.A., Hegde VL, Nagarkatti M.(2009). Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem., 1:1333-49.

Nichols, J.M., Kaplan, B.L.F. (2020). Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res, Feb 27;5(1):12-31. Doi: 10.1089/can.2018.0073.

Peyravian, N., Deo, S., Daunert, S, Jimenez, J-J. (2020). Cannabidiol as a Novel Therapeutic for Immune Modulation. Immunotargets Ther., Aug 18, 9: 131-140. Doi: 10.2147/ITT.S263690.

Rojas-Valverde, D. (2021). Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Front Physiol, Aug 3;12:722550. Doi: 10.3389/fphys.2021.722550.

Scrimali, T (2008). Entropy of Mind and Negative Entropy a Cognitive and Complex Approach to Schizophrenia and its Therapy. London: Karnac Books.

Scrimali, T. (2020). NegEnt: A cannabidiol-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151.

Scrimali, T. (2020). NegEnt: A cannabidiolo-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151. Consultabile e scaricabile cliccando qui.

Scrimali, T. (2022). NegEnt: Cannabidiolo Liposomiale in Medicina Umana e Veterinaria. Enna: Edizioni ALETEIA Publisher. Su Amazon Libri.

Scrimali, T. (2023). Cannabidiol, NegEnt and Panic Disorder. Preprints.org. doi: doi:10.20944/preprints202302.0464.v1

Scrimali, T. (2023). Safety and Tolerability of NegEnt, a New Botanical Product Based on Liposomal Cannabidiol: A Case Series Report. Journal of Nutraceuticals and Food Science. Vol.8 No.1: 08.

Sheriff, T. Lin, M-J., Dubin, D., Khorasani, H. (2020). The potential role of cannabinoids in dermatology. J. Dermatolog. Treat., Dec; 31(8): 839-845. Doi: 10.1080/09546634.2019.1675854.

Stanley, C.P., Hind, W.H., O’Sullivan, S.O.(2013). Is the cardiovascular system a therapeutic target for cannabidiol? Br J Clin Pharmacol, Feb;75(2):313-22. Doi: 10.1111/j.1365-2125.2012.04351.x.

Sumpter, L. (2021). Che legame c’è tra cannabis, CBD e gastrite? – RQS Blog.

Toncheva-Moncheva, N., Ivanov, M., & Markov, V. (2023). Micellar CBD formulations for prolonged therapeutic effects in respiratory diseases. Journal of Clinical Pulmonology, 32(1), 56-67. https://doi.org/10.1016/j.jcpul.2023.01.012.

Vasudevan K, Stahl V. Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples. J Cannabis Res. 2020;2(1):20. doi:10.1186/s42238-020-00027-z.

WHO, (2018). CANNABIDIOL (CBD) Critical Review Report. Expert Committee on Drug Dependence, Fortieth Meeting, Geneva, 4-7 June 2018.